PHP
IDYA icon

Parkman Healthcare Partners’s IDEAYA Biosciences IDYA Stock Holding History

Parkman Healthcare Partners’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-66,332
Closed -$2.91M – 99
2024
Q1 		$2.91M Sell
66,332
-63,933
-49% -$2.75M 0.36% 73
2023
Q4 		$4.63M Sell
130,265
-2,436
-2% -$72.7K 0.65% 50
2023
Q3 		$3.58M Buy
132,701
+5,362
+4% +$136K 0.66% 45
2023
Q2 		$2.99M Buy
+127,339
New +$2.62M 0.52% 58

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Parkman Healthcare Partners's IDYA Position: Q2 2024 in Review

Parkman Healthcare Partners sold out of IDEAYA Biosciences (IDYA) in Q2 2024, closing a stake of 66,332 shares — an estimated $2.91M sold.

Parkman Healthcare Partners first reported a position in IDYA in Q2 2023 and held it in 4 quarters. The position peaked at $4.63M in Q4 2023. 199 funds tracked by Wall St. Rank hold IDYA as of Q2 2024.

  • Parkman Healthcare Partners reported no remaining IDEAYA Biosciences position as of Q2 2024 after selling out during the quarter.
  • Parkman Healthcare Partners sold 66,332 IDEAYA Biosciences shares in Q2 2024, an estimated $2.91M.
  • Parkman Healthcare Partners first reported a position in IDEAYA Biosciences in Q2 2023 and held it in 4 quarters.
  • Parkman Healthcare Partners's IDEAYA Biosciences position peaked at $4.63M in Q4 2023.
  • 199 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2024.

Based on Parkman Healthcare Partners's 13F filing for Q2 2024, filed 14 Aug 2024.